Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4078-4082

  Borstnar, S ^a   Erzen, B ^a   Gmeiner Stopar, T ^a   Kocjan, T ^a   Arnol, M ^a   Kandus, A ^a   Kovac D ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; CALCIUM; CINACALCET; COLLAGEN; CORTICOSTEROID; CREATININE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOREARM; GASTROINTESTINAL SYMPTOM; HIP; HUMAN; HYPERPARATHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUMBAR SPINE; MALE; NAUSEA; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VOMITING;

HUMANS; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; NAPHTHALENES;

EID: 78650452732     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.059     Document Type: Conference Paper

References (20)

1. U. Kunzendorf, B.K. Kramer, and W. Arns Bone disease after renal transplantation Nephrol Dial Transplant 23 2006 450
2. A.E. Kruse, U. Eisenberger, and F.J. Frey The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism Nephrol Dial Transplant 20 2005 1311
3. I. Szwarc, A. Argiles, and V. Garrigue Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism Transplantaton 82 2006 675
4. N. Leca, M. Laftavi, and A. Gundroo Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet Am J Transplant 6 2006 2391
5. P.U. Torres, D. Prie, and L. Beck New therapies for uremic secondary hyperparathyroidism J Ren Nutr 16 2006 87
6. T. Apostolou, K. Kollia, and L. Damianou Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet Transplant Proc 38 2006 3514
7. F.J. Toro Prieto, G. Bernal Bianco, and M. Navarro Garcia Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism Transplant Proc 41 2009 2144
8. A.A. Ziyad The new role of calcimimetics as vasculotropic agents Kidney Int 75 2009 9
9. A.L. Serra, A.A. Schwarz, and F.H. Wick Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism Nephrol Dial Transplant 20 2005 1315
10. T.R. Srinivas, J.D. Schold, and K.L. Womer Improvement in hypercalcemia with cinacalcet after kidney transplantation Clin J Am Soc Nephrol 1 2006 323
11. C. Bergua, J.V. Torregrosa, and D. Fuster Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism Transplantation 86 2008 413
12. A.L. Serra, S.C. Braun, and A. Starke Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation Am J Transplant 8 2008 803
13. J.M. El-Amm, M.D. Doshi, and A. Singh Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation Transplantation 83 2007 546
14. N. Kamar, I. Gennero, and L. Spataru Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose Nephrol Dial Transplant 23 2008 3720
15. T. Apostolou, L. Damianou, and V. Kotsiev Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet Clin Nephrol 65 2006 374
16. A.L. Serra, R. Savoca, and A.R. Huber Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients Nephrol Dial Transplant 22 2007 577
17. E. Maass, G.A. Mueller, and T. Heller Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report Transplant Proc 39 2007 3468
18. Y.H.H. Lien, A.L. Silva, and D. Whittman Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism Nephrol Dial Transplant 20 2005 1232
19. M. Peacock, M.A. Bolognese, and M. Borofsky Cinacalcet treatment of primarny hyperparathyroidism: biochemical and bone densitometric outcomes in a five year study J Clin Endocrin Metab 94 2009 4860
20. C. Richard, R. Huo, and R. Samadfam The calcium sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover J Bone Miner Res 25 2010 1627